Keywords
Vitamin D
How to Cite
Abstract
Introduction: Systemic Lupus Erythematosus (SLE) is a systemic inflammatory disease associated with genetic, environmental, hormonal and immunological factors. One possible factor is the deficiency of vitamin D. Vitamin D is a hormone that has a significant number of functions and actions in various physiological processes in the body and has a very important role in the immune system. Therefore prevalence of vitamin D deficiency has been linked to the severity of autoimmune diseases such as SLE. Objectives: To determine the prevalence of insufficiency and deficit of vitamin D in patients with SLE at follow up in the Rheumatology Department at the “Hospital de Clínicas”. Methods: Observational Trial, analytically based on the record of epidemiological data (i.e. sex and age) and clinical ( i.e. treatment with supplements) and the determination of concentrations of vitamin D and the phospho-calcium metabolism parameters of patients diagnosed with SLE. A vitamin D deficiency is determined as values less than 30 ng /dl. The dosage of vitamin D was performed by chemiluminescence with ARCHITEC. This trial is a preliminary analysis that is part of a project supported by CONACYT on the role of vitamin D in patients with SLE. Results: We included 77 patients, of whom 94.8 % (73/77) were female. The average age of patients at the time the study was 28.9 ± 8.20 years. All patients received calcium supplements associated with vitamin D. 29.87 % (23/77) of patients had a deficiency of vitamin D, the average value of the concentration thereof 32.2 ± 13.40 ng /ml. 94.8 % (73/77) of the population had normal serum calcium and the total population had a normal phosphoremia. As for the dosage of PTH, it was found that 27.3 % (21/77) have high values of PTH. Conclusion: In this cohort of patients with SLE, a significant percentage of patients with vitamin D deficiency was observed, despite their receiving supplements. This is a preliminary analysis that is part of a project studying the role of vitamin D in SLE and as a basis to create recommendations on the use of vitamin supplements as part of the therapeutic arsenal for this disease.
References
(1) Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol. 2003;56:481-490.
(2) D’ Crux DP, Khamashta MA, Hughes GR. Systemic lupuserythematosus. Lancet. 2007;369(9561):587-96.
(3) Li PH, Hing W, Wong S, et al. Relationship between autoantibody clustering and clinical subsets in SLE: Cluster and association analyses in Hong Kong Chinese. Rheumatology (Oxford). 2013; 52:337-345.
(4) Uva L, Miguel D, Pinheiro C, Freitas JP, Marques Gomes M, Filipe P. Cutaneous manifestations of systemic lupus erythematosus. Autoimmune Dis. 2012;2012:834291.
(5) Holick MF (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 80:1678S-1688S
(6) Vinh qu c Lu‘o‘ngK, Nguy n LT (2013) The beneficial role of vitamin D in obesity: possible genetic and cell signaling mechanisms. Nutr. J12:89
(7) HolickMF (2007) Vitamin D deficiency. N Engl JMed. 357:266-281
(8) GrantWB (2006) Epidemiology of disease risks in relation to vitamin D insufficiency. Prog Biophys Mol Biol. 92:65-79.
(9) Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C (2010) Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 10:482-496.
(10) Arnson Y, Amital H, Shoenfeld Y (2007) Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis. 66:1137-1142.
(11) Adorini L, Penna G (2008) Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol. 4:404-412.
(12) Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM(2008) Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther. 324:23-33.
(13) Lemire JM, Ince A, TakashimaM(1992) 1,25-Dihydroxyvitamin D3attenuates the expression of experimental murine lupus of MRL/l mice. Autoimmunity. 12:143-148.
(14) O‘Regan S, Chesney RW, Hamstra A, Eisman JA, O‘Gorman AM,Deluca HF (1979) Reduced serum 1,25-(OH)2 vitamin D3 levels in prednisone-treated adolescents with systemic lupus erythematosus. Acta Paediatr Scand. 68:109-111.
(15) Sakthiswary R, Raymond AA (2013) The clinical significance of vitamin D in systemic lupus erythematosus: a systematic review. PLoS One. 8:e55275.
(16) Kamen DL, Aranow C (2008) The link between vitamin D deficiency and systemic lupus erythematosus. Curr Rheumatol Rep. 10:273-280.
(17) Bonakdar ZS, Jahanshahifar L, Jahanshahifar F, Gholamrezaei A (2011) Vitamin D deficiency and its association with disease activity in new cases of systemic lupus erythematosus. Lupus. 20:1155-1160.
(18) Oneil S, Cervera R. Sistemyc Lupus erythematosus. Best Prac Res Clin Rheumatol. 2010;24(6):841-55.
(19) Souto, M. I. D., Coelho, A., Guo, C., Mendonça, L. M. C., Argolo, S., Papi, J. A. S., & Farias, M. L. F. (2011). Vitamin D insufficiency in Brazilian patients with SLE: prevalence, associated factors, and relationship with activity. Lupus. 20(10),1019-1026.
(20) Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM et al (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 96:53-58.
(21) Monticielo OA, Teixeira TM, Chies JA, Brenol JC, Xavier RM (2012) Vitamin D and polymorphisms of VDR gene in patients with systemic lupus erythematosus. Clin Rheumatol. 31:1411-1421.
(22) Costenbader KH, Feskanich D, Holmes M, Karlson EW, Benito- Garcia E (2008) Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis. 67:530-535.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2016 Paraguayan Journal of Rheumatology